B-cell receptor variable region specific for pneumococcal capsular polysaccharide epitope (BCR-PnCP) (BCR-PnCP)

B-cell receptor (BCR) variable regions specific for pneumococcal capsular polysaccharide (PnCP) epitopes are the primary immunological components responsible for recognizing and neutralizing Streptococcus pneumoniae. These receptors, found on the surface of specific B-cell clones, bind to the complex carbohydrate structures that form the bacterial capsule, which is the main virulence factor of the pathogen (Source: Richter et al., Journal of Immunology, 2013). Upon activation by vaccines or natural infection, these B cells differentiate into plasma cells that secrete antibodies (primarily IgG) that facilitate opsonophagocytosis by neutrophils and macrophages. In clinical practice, these BCRs are the functional targets of pneumococcal vaccines, which aim to expand the repertoire of PnCP-specific B cells to provide long-term immunity (Source: FDA Label for Prevnar 20). The diversity of these variable regions is critical because S. pneumoniae exists in over 100 distinct serotypes, each with a unique polysaccharide structure. Failure to generate an adequate response from these BCRs, particularly in young children or the elderly, significantly increases the risk of invasive pneumococcal diseases such as pneumonia, meningitis, and sepsis (Source: CDC Pink Book, 2021).

Other names

B-cell receptor / antibody variable regions specific for pneumococcal capsular polysaccharide epitopesAnti-pneumococcal capsular polysaccharide antibodiesPnCP-specific B-cell receptorsPneumococcal-specific immunoglobulinsAnti-CPS BCRsPneumococcal polysaccharide-specific variable regions

Pneumococcal vaccines contain purified capsular polysaccharides that serve as antigens; these antigens bind to and cross-link the variable regions of specific B-cell receptors, inducing clonal expansion, affinity maturation, and the secretion of high-affinity antibodies that neutralize and opsonize Streptococcus pneumoniae (Source: Pollard et al., Nature Reviews Immunology, 2009).